International immunopharmacologyHumansStomach NeoplasmsGlucoseAnimalsDrug Resistance
Glucose metabolism reprogramming in gastric cancer: Implications for tumor.
Xiang Li, Xueqin Cao, Yuanfu Wang, Yonghao Deng, Elizabeth Rosalind Thomas, Wudian Xiao, Wenjun Wang, Linxia Xu, Qidan He
Published: 202510.1016/j.intimp.2025.115630
Abstract
Gastric cancer (GC) is a leading cause of cancer-related mortality worldwide, with advanced stages often showing limited therapeutic response and frequent drug resistance. Growing evidence underscores glucose metabolism reprogramming as a pivotal mec…
Preview only. Read the full abstract at the source